Xanthogranulomatous disease of bone is exceptionally uncommon. Clinically, radiologically and pathologically, it is a great imitator of malignancy. While there are few reports on the surgical pathology of this rare entity, there is no published report on its cytopathologic characteristics. We report herein the case of a 44-year-old male who was evaluated at The Johns Hopkins Hospital for a 2.3-cm painful soft tissue mass present within the medullary canal of the distal tibia with destruction of the overlying cortex. A computed tomography-guided fine needle aspiration biopsy revealed abundant histiocytes and occasional giant cells in an inflammatory background. This was interpreted as a 'histiocyte-rich lesion,' and an excisional biopsy was recommended. Subsequent curettage was performed, and the histological material was diagnosed as 'xanthogranuloma of bone.' The rarity of xanthogranuloma of bone and its resemblance to the more common reactive and malignant bone neoplasms may present diagnostic challenges.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1159/000345900 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Deep juvenile xanthogranuloma invading the left tensor fasciae latae muscle: a case report and a literature review.
J Clin Exp Hematop
December 2024
Division of Pediatrics and Perinatology, Department of Multidisciplinary Internal Medicine, School of Medicine, Tottori University Faculty of Medicine, Yonago, Japan.
Article Synopsis
- Juvenile xanthogranuloma (JXG) is a rare benign condition primarily affecting neonates and young children, often presenting as skin lesions, but intramuscular JXG is much less common, accounting for only 0.6% of cases.
- A case involving a 5-month-old girl showed a slow-growing lump in her left thigh, which was diagnosed as deep JXG after imaging, biopsy, and surgical resection.
- Histological findings revealed characteristics typical of JXG, and despite initial concerns about tumor margins, the patient has shown no signs of recurrence over 48 months post-surgery, highlighting the importance of proper diagnosis and monitoring.
Personalized Medicine in Histiocytic Disorders: Novel Targets in Patients Without MAPK Alterations.
JCO Precis Oncol
November 2024
Department of Hematology, Mayo Clinic, Rochester, MN.
Purpose: BRAF and MEK inhibitors are standard treatments in histiocytic disorders, such as Erdheim-Chester disease (ECD). Some patients lack MAPK-pathway alterations, making these treatments less effective.
Methods: We describe three patients with histiocytic disorders who have novel non-MAPK pathway alterations.
Subfoveal Choroidal Thickness in Patients with Histiocytosis and Multimodal Imaging Features of Choroidal Infiltrates.
Ophthalmol Retina
November 2024
Weill Cornell Medical College, New York, New York; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York; Early Drug Development Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
Purpose: To evaluate choroidal findings in patients with histiocytosis, including subfoveal choroidal thickness (SFCT), and multimodal imaging in eyes with choroidal infiltrates visible by ophthalmoscopy and determine if abnormalities change with histiocytosis-directed (kinase inhibitor) therapy.
Design: Retrospective comparative study at single tertiary cancer referral center.
Participants: Ninety-one patients with histiocytosis and 41 age- and sex-matched controls.
Multisystem ALK-Positive Histiocytosis With DCTN1::ALK Fusion in an Adult, Responsive to Alectinib: Case Report and Literature Review.
J Cutan Pathol
January 2025
Department of Dermatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Anaplastic lymphoma kinase (ALK)-positive histiocytosis has emerged as a clinically relevant diagnosis featuring a wide span of clinical presentations, which are unified by the presence of ALK-positive histiocytes on histopathology and molecular drivers involving the ALK kinase gene. This report presents an adult case of multisystem ALK-positive histiocytosis with xanthogranuloma-like features on histopathology that was responsive to ALK inhibition, and includes a review of ALK-positive histiocytoses with cutaneous involvement reported in the literature. A 56-year-old male developed a widespread eruption of red-brown papules on the face, trunk, and upper extremities.
View Article and Find Full Text PDFSuccessful treatment with dupilumab of adult-onset asthma and periocular xanthogranuloma syndrome overlapping IgG4-related disease.
Joint Bone Spine
December 2024
Service de médecine interne, hôpital Avicenne, AP-HP, Bobigny, France; Faculté de médecine SMBH, université Sorbonne Paris Nord, Bobigny, France; UMR1125, LI2P, université Sorbonne Paris Nord, Bobigny, France.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!